ATE287397T1 - Chinoline derivate und ihre anwendung als antitumor agentien - Google Patents

Chinoline derivate und ihre anwendung als antitumor agentien

Info

Publication number
ATE287397T1
ATE287397T1 AT02752656T AT02752656T ATE287397T1 AT E287397 T1 ATE287397 T1 AT E287397T1 AT 02752656 T AT02752656 T AT 02752656T AT 02752656 T AT02752656 T AT 02752656T AT E287397 T1 ATE287397 T1 AT E287397T1
Authority
AT
Austria
Prior art keywords
formula
compound
antitumor agents
salt
chinoline derivatives
Prior art date
Application number
AT02752656T
Other languages
English (en)
Inventor
Jerome P Horwitz
Stewart T Hazeldine
Thomas H Corbett
Lisa Polin
Original Assignee
Univ Wayne State
Jerome P Horwitz
Stewart T Hazeldine
Thomas H Corbett
Lisa Polin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wayne State, Jerome P Horwitz, Stewart T Hazeldine, Thomas H Corbett, Lisa Polin filed Critical Univ Wayne State
Application granted granted Critical
Publication of ATE287397T1 publication Critical patent/ATE287397T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
AT02752656T 2001-07-31 2002-07-31 Chinoline derivate und ihre anwendung als antitumor agentien ATE287397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30914401P 2001-07-31 2001-07-31
PCT/US2002/024442 WO2003011832A1 (en) 2001-07-31 2002-07-31 Quinoline derivatives and use thereof as antitumor agents

Publications (1)

Publication Number Publication Date
ATE287397T1 true ATE287397T1 (de) 2005-02-15

Family

ID=23196886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02752656T ATE287397T1 (de) 2001-07-31 2002-07-31 Chinoline derivate und ihre anwendung als antitumor agentien

Country Status (22)

Country Link
US (3) US6867219B2 (de)
EP (1) EP1412332B1 (de)
JP (1) JP4310185B2 (de)
KR (1) KR20040055774A (de)
AT (1) ATE287397T1 (de)
AU (1) AU2002355747B2 (de)
CA (1) CA2456173A1 (de)
DE (1) DE60202682T2 (de)
DK (1) DK1412332T3 (de)
EA (1) EA007205B1 (de)
ES (1) ES2236548T3 (de)
GE (1) GEP20063754B (de)
HU (1) HUP0401562A2 (de)
IL (2) IL160082A0 (de)
MX (1) MXPA04000968A (de)
NO (1) NO326463B1 (de)
NZ (1) NZ530806A (de)
PL (1) PL367340A1 (de)
PT (1) PT1412332E (de)
UA (1) UA75691C2 (de)
WO (1) WO2003011832A1 (de)
ZA (1) ZA200401185B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001250783A1 (en) * 2000-02-29 2001-09-12 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
ATE287397T1 (de) * 2001-07-31 2005-02-15 Univ Wayne State Chinoline derivate und ihre anwendung als antitumor agentien
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
BR0313789A (pt) * 2002-08-24 2005-07-05 Zentaris Gmbh Medicamento contendo disorazóis e seus derivados para o tratamento de doenças tumorais malignas e benignas
US7470788B2 (en) 2005-09-07 2008-12-30 Wayne State University Antitumor agents
US20070054938A1 (en) * 2005-09-07 2007-03-08 Horwitz Jerome P Antitumor agents
US8183379B2 (en) 2005-09-07 2012-05-22 Wayne State University Antitumor agents
EP1897542A1 (de) * 2006-09-07 2008-03-12 Sanofi-Aventis Wässrige Formulierung enthaltend einen antitumoralen Wirkstoff
JO2685B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
WO2009002955A1 (en) * 2007-06-27 2008-12-31 Sanofi-Aventis U.S. Llc Process for the preparation of (2r)-2-[4-(7-bromo-2-quinolyloxy)phenoxy]propanoic acid
WO2012170384A1 (en) 2011-06-06 2012-12-13 Chevron Phillips Chemical Company Lp Use of metallocene compounds for cancer treatment
WO2024132001A1 (en) * 2022-12-21 2024-06-27 Charles University, Faculty Of Pharmacy In Hradec Kralove Multitarget nuclear receptor ligands based on 2-(4-(quinolin-2-yloxy)phenoxy)propanoic acid and 2-(4-(quinoxalin-2-yloxy)phenoxy)propanoic acid for the treatment of metabolic and liver diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6033389B2 (ja) 1979-02-22 1985-08-02 日産化学工業株式会社 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤
US5364831A (en) 1980-08-06 1994-11-15 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US6197728B1 (en) 1980-08-06 2001-03-06 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US5250690A (en) * 1985-05-02 1993-10-05 Dowelanco Haloalkoxy anilide derivatives of 2-4(-heterocyclic oxyphenoxy)alkanoic or alkenoic acids and their use as herbicides
ATE287397T1 (de) * 2001-07-31 2005-02-15 Univ Wayne State Chinoline derivate und ihre anwendung als antitumor agentien
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
US7470788B2 (en) * 2005-09-07 2008-12-30 Wayne State University Antitumor agents

Also Published As

Publication number Publication date
US20050159447A1 (en) 2005-07-21
US20030144321A1 (en) 2003-07-31
JP4310185B2 (ja) 2009-08-05
IL160082A (en) 2009-06-15
NO326463B1 (no) 2008-12-08
NO20040382L (no) 2004-03-26
PL367340A1 (en) 2005-02-21
EP1412332A1 (de) 2004-04-28
CA2456173A1 (en) 2003-02-13
IL160082A0 (en) 2004-06-20
WO2003011832A1 (en) 2003-02-13
EA200400219A1 (ru) 2004-12-30
NZ530806A (en) 2006-05-26
UA75691C2 (en) 2006-05-15
DK1412332T3 (da) 2005-05-30
US7241894B2 (en) 2007-07-10
EP1412332B1 (de) 2005-01-19
GEP20063754B (en) 2006-02-27
DE60202682D1 (de) 2005-02-24
ZA200401185B (en) 2004-10-21
US20070232643A1 (en) 2007-10-04
US6867219B2 (en) 2005-03-15
EA007205B1 (ru) 2006-08-25
HUP0401562A2 (hu) 2004-12-28
PT1412332E (pt) 2005-06-30
US7507749B2 (en) 2009-03-24
ES2236548T3 (es) 2005-07-16
DE60202682T2 (de) 2005-12-29
JP2004538314A (ja) 2004-12-24
KR20040055774A (ko) 2004-06-26
AU2002355747B2 (en) 2007-12-20
MXPA04000968A (es) 2005-02-17

Similar Documents

Publication Publication Date Title
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
DE60140814D1 (de) N-phenyl-2-pyrimidine-amine derivatives
DE60010076D1 (de) Chinolinderivate als antibakterielle mittel
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
ATE475652T1 (de) Chinazolinderivate
ECSP066314A (es) Derivados piridilo y su uso como agentes terapéuticos
EA200700099A1 (ru) Производные пиридина
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
ATE287397T1 (de) Chinoline derivate und ihre anwendung als antitumor agentien
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
EA200701780A1 (ru) Противоопухолевое средство
ATE424200T1 (de) Solubilisierte topoisomerase-gift-mittel
EE05035B1 (et) 1-[fenüül-(8-kinolinüül)metüül]piperasiini derivaadid ning nende kasutamine meditsiinis
TNSN08093A1 (en) Quinoline derivatives and use as antitumor agents
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
EE200200660A (et) Akrüloüüldistamütsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritudravimpreparaat
ATE476420T1 (de) Alkaloidverbindungen und ihre verwendung als antimalariamittel
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
HK1112915A (en) Quinoline derivatives and use as antitumor agents
TW200744596A (en) Antitumor agents
DE60022047D1 (de) Antivirale therapie
DE60104288D1 (de) Antivirale therapie
BR0211629A (pt) Composto, composição farmacêutica, uso do composto, e, método terapêutico para tratar câncer em um mamìfero

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1412332

Country of ref document: EP

REN Ceased due to non-payment of the annual fee